Healthcare
H2 Equity sells Healthcare 21 to trade
H2 invested in the medical supplies business in 2018, merging it with portfolio company Aquilant
Talde invests in AJL Ophtalmic
GP plans to consolidate the company's position in the ophthalmology sector, both in Spain and internationally
Future Planet Capital acquires Midven
Midven was founded in 1990 and focuses on West Midlands-based science and technology investments
PE-backed Synlab announces IPO intention
Cinven, Novo Holdings and OTTP hold stakes in the Germany-based laboratory diagnostics group
MTIP holds first close for second fund
Digital-health-focused growth investor has a hard-cap of €250m and target of €200m for MTIP Fund II
EQT in exclusivity to acquire Cerba from Partners Group
Medical diagnostics business has previously been backed by sponsors including Astorg, IK and PAI
Gyroscope Therapeutics raises $148m in Forbion-led series C
Series-C round for the gene therapy company is led by Forbion’s Growth Opportunities Fund
Aksia buys Medical International Research
GP invests in the company via Aksia Capital V, which targets European businesses with potential for high-growth
ICG invests in $80m round for Eliem Therapeutics
This is the first investment made by ICG Life Sciences, which was launched in January 2021
Compass Partners sells Rodenstock to Apax Partners
€1.5bn deal is the fourth PE-backed buyout of the ophthalmic lens and glasses frames producer
Nordic Capital acquires minority stake in Leo Pharma
GP's stake is reportedly smaller than 25%, with the current owner remaining as the majority shareholder
Miura backs dental specialist Proclinic
GP plans to boost the company's growth in Spain and bolster its international expansion, primarily in Italy and France
SEP sells Dotmatics to Insight Partners' Insightful Science
Scottish Equity Partners invested in the scientific informatics software in 2017
Capiton heads for summer final close for sixth fund
Capiton VI has a €550m target; Capiton V held a final close in January 2015 on €440m
Albion exits Berkley Care for 2.5x return
Sale ends a seven-year holding period for Albion, which initially invested £16m in the business
Magnum exits Ita Mental Health to Korian
Sale ends a four-year holding period for the GP, which invested in the company via Magnum Capital II
Triton Smaller Mid-Cap Fund II closes on €815m
Fund will follow the same sector and value-creation strategy as TSM I, albeit with larger equity tickets
Capiton buys majority stake in Wundex
Wound care product supplier was a portfolio company of BE Beteiligungen prior to the sale to Capiton
CVC buys Cooper from Charterhouse for €2.2bn
CVC invests via fund VII, while Charterhouse will reinvest in the OTC pharmaceuticals business
ICG acquires Lucid Group from LDC
Sale ends a four-year holding period for LDC, which invested £11m in the company in exchange for a minority stake
Claris Ventures leads £15.2m series-B for NeoPhore
2Invest, 3B Future Health Fund, Astellas Venture Management and CRT Pioneer Fund also take part in the round
Triton invests in NPM Capital's Bergman Clinics
Investment is being made in partnership with NPM Capital and the Malenstein family
DCVC Bio leads $17m series-A round for BioPhero
Startup will use the funding to start production of its first product and make it available worldwide
BlackRock joins $100m series-C funding for Exscientia
Company plans to use the financing to expand its portfolio of drugs and grow its artificial intelligence capabilities